“Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch”
“Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch”
Presented by Thawatchai Khuanjing, BSc.
May 05, 2022 (Thursday) 10.30 A.M.-12.00 P.M.

















